SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 541 filers reported holding SEAGEN INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,751,250 | +21.4% | 564,465 | +10.1% | 0.06% | +29.8% |
| Q2 2023 | $98,666,351 | -59.8% | 512,659 | -57.7% | 0.05% | -61.8% |
| Q1 2023 | $245,306,811 | +9.9% | 1,211,571 | -30.2% | 0.12% | +6.0% |
| Q4 2022 | $223,110,616 | -2.0% | 1,736,134 | +4.3% | 0.12% | -6.5% |
| Q3 2022 | $227,754,000 | -11.8% | 1,664,501 | +14.1% | 0.12% | -3.1% |
| Q2 2022 | $258,146,000 | +12.6% | 1,458,952 | -8.3% | 0.13% | +39.1% |
| Q1 2022 | $229,237,000 | -0.4% | 1,591,357 | +6.9% | 0.09% | +10.8% |
| Q4 2021 | $230,153,000 | -5.7% | 1,488,695 | +3.5% | 0.08% | -9.8% |
| Q3 2021 | $244,013,000 | +15.6% | 1,437,773 | +7.6% | 0.09% | +13.6% |
| Q2 2021 | $211,017,000 | -0.6% | 1,336,448 | -12.5% | 0.08% | -5.8% |
| Q1 2021 | $212,299,000 | -7.4% | 1,528,065 | +16.8% | 0.09% | -11.3% |
| Q4 2020 | $229,234,000 | – | 1,308,731 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |